Tabuk Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Saudi Arabia · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Aig Building House Project King Abdulazi...Phone Number
+966 114774946Website
www.tabukpharmaceuticals.comRevenue
$72 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
5
1
1
1
1
About Tabuk Pharmaceuticals
Tabuk Pharmaceuticals is a generic pharmaceutical company that delivers quality cost-effective prices in the regulated markets of the MENA region. The company provides to the major therapeutic areas of GI and diabetes, cardiovascular, musculoskeletal, respiratory, infection, and the central nervous system pharmaceuticals.Explore more
Tabuk Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Tabuk Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Tabuk Pharmaceuticals recently announced quarterly report
Product Launch: Get notified when Tabuk Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Tabuk Pharmaceuticals
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Tabuk Pharmaceuticals is spiking on competitors!
Click to see if Tabuk Pharmaceuticals had a recent Job posting/layoffs
Tabuk Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Tabuk Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Tabuk Pharmaceuticals has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Tabuk Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Tabuk Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Tabuk Pharmaceuticals.
Tabuk Pharmaceuticals Tech Stack
A closer look at the technologies used by Tabuk Pharmaceuticals
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Tabuk Pharmaceuticals News & Media
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
Vibativ ® treats patients with pneumonia and serious skin infections NASHVILLE, Tenn. and RIYADH, Saudi Arabia, Sept. 29, 2025 /PRNewswire/ -- Specialty pharmaceutical companies Tabuk Pharmaceutical Manufacturing Company a fully owned subsidiary of Astra Industrial Group and a leading...Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia
GUANGZHOU, China, Dec. 24, 2024 /PRNewswire/ -- Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company has partnered with Tabuk Pharmaceutical Manufacturing...Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, May 9, 2024 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into an exclusive licensing agreement with Tabuk Pharmaceuticals Manufacturing Company ("Tabuk"), for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery in key regions of the Middle East and North AfricaLevolta Pharmaceuticals Partners with Tabuk Pharmaceuticals for Commercialization of Investigational Osteoarthritis Therapy in Middle East and Africa
BETHLEHEM, Pa., June 1, 2023 /PRNewswire/ -- Levolta Pharmaceuticals, Inc. has entered into an exclusive licensing and distribution agreement for VOLT01 with Tabuk Pharmaceutical Manufacturing Company of Riyadh, Saudi Arabia, for the commercialization of an investigational osteoarthritis...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Tabuk Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Tabuk Pharmaceuticals is a generic pharmaceutical company that delivers quality cost-effective prices in the regulated markets of the MENA region. The company provides to the major therapeutic areas of GI and diabetes, cardiovascular, musculoskeletal, respiratory, infection, and the central nervous system pharmaceuticals.... Read More
